Use of additives, scaffolds and extracellular matrix components for improvement of human pancreatic islet outcomes in vitro: A systematic review.

IF 1.9 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM
Islets Pub Date : 2017-09-03 Epub Date: 2017-07-05 DOI:10.1080/19382014.2017.1335842
Natália Emerim Lemos, Letícia de Almeida Brondani, Cristine Dieter, Jakeline Rheinheimer, Ana Paula Bouças, Cristiane Bauermann Leitão, Daisy Crispim, Andrea Carla Bauer
{"title":"Use of additives, scaffolds and extracellular matrix components for improvement of human pancreatic islet outcomes in vitro: A systematic review.","authors":"Natália Emerim Lemos,&nbsp;Letícia de Almeida Brondani,&nbsp;Cristine Dieter,&nbsp;Jakeline Rheinheimer,&nbsp;Ana Paula Bouças,&nbsp;Cristiane Bauermann Leitão,&nbsp;Daisy Crispim,&nbsp;Andrea Carla Bauer","doi":"10.1080/19382014.2017.1335842","DOIUrl":null,"url":null,"abstract":"<p><p>Pancreatic islet transplantation is an established treatment to restore insulin independence in type 1 diabetic patients. Its success rates have increased lately based on improvements in immunosuppressive therapies and on islet isolation and culture. It is known that the quality and quantity of viable transplanted islets are crucial for the achievement of insulin independence and some studies have shown that a significant number of islets are lost during culture time. Thus, in an effort to improve islet yield during culture period, researchers have tested a variety of additives in culture media as well as alternative culture devices, such as scaffolds. However, due to the use of different categories of additives or devices, it is difficult to draw a conclusion on the benefits of these strategies. Therefore, the aim of this systematic review was to summarize the results of studies that described the use of medium additives, scaffolds or extracellular matrix (ECM) components during human pancreatic islets culture. PubMed and Embase repositories were searched. Of 5083 articles retrieved, a total of 37 articles fulfilled the eligibility criteria and were included in the review. After data extraction, articles were grouped as follows: 1) \"antiapoptotic/anti-inflammatory/antioxidant,\" 2) \"hormone,\" 3) \"sulphonylureas,\" 4) \"serum supplements,\" and 5) \"scaffolds or ECM components.\" The effects of the reviewed additives, ECM or scaffolds on islet viability, apoptosis and function (glucose-stimulated insulin secretion - GSIS) were heterogeneous, making any major conclusion hard to sustain. Overall, some \"antiapoptotic/anti-inflammatory/antioxidant\" additives decreased apoptosis and improved GSIS. Moreover, islet culture with ECM components or scaffolds increased GSIS. More studies are needed to define the real impact of these strategies in improving islet transplantation outcomes.</p>","PeriodicalId":14671,"journal":{"name":"Islets","volume":"9 5","pages":"73-86"},"PeriodicalIF":1.9000,"publicationDate":"2017-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/19382014.2017.1335842","citationCount":"17","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Islets","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/19382014.2017.1335842","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/7/5 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 17

Abstract

Pancreatic islet transplantation is an established treatment to restore insulin independence in type 1 diabetic patients. Its success rates have increased lately based on improvements in immunosuppressive therapies and on islet isolation and culture. It is known that the quality and quantity of viable transplanted islets are crucial for the achievement of insulin independence and some studies have shown that a significant number of islets are lost during culture time. Thus, in an effort to improve islet yield during culture period, researchers have tested a variety of additives in culture media as well as alternative culture devices, such as scaffolds. However, due to the use of different categories of additives or devices, it is difficult to draw a conclusion on the benefits of these strategies. Therefore, the aim of this systematic review was to summarize the results of studies that described the use of medium additives, scaffolds or extracellular matrix (ECM) components during human pancreatic islets culture. PubMed and Embase repositories were searched. Of 5083 articles retrieved, a total of 37 articles fulfilled the eligibility criteria and were included in the review. After data extraction, articles were grouped as follows: 1) "antiapoptotic/anti-inflammatory/antioxidant," 2) "hormone," 3) "sulphonylureas," 4) "serum supplements," and 5) "scaffolds or ECM components." The effects of the reviewed additives, ECM or scaffolds on islet viability, apoptosis and function (glucose-stimulated insulin secretion - GSIS) were heterogeneous, making any major conclusion hard to sustain. Overall, some "antiapoptotic/anti-inflammatory/antioxidant" additives decreased apoptosis and improved GSIS. Moreover, islet culture with ECM components or scaffolds increased GSIS. More studies are needed to define the real impact of these strategies in improving islet transplantation outcomes.

Abstract Image

添加剂、支架和细胞外基质成分在体外改善人类胰岛结果中的应用:一项系统综述。
胰岛移植是恢复1型糖尿病患者胰岛素独立性的一种既定治疗方法。最近,由于免疫抑制疗法以及胰岛分离和培养的改进,其成功率有所提高。众所周知,存活移植胰岛的质量和数量对实现胰岛素独立性至关重要,一些研究表明,在培养过程中,大量胰岛丢失。因此,为了在培养期间提高胰岛产量,研究人员在培养基和替代培养设备(如支架)中测试了各种添加剂。然而,由于使用了不同类别的添加剂或设备,很难对这些策略的好处得出结论。因此,本系统综述的目的是总结在人类胰岛培养过程中使用培养基添加剂、支架或细胞外基质(ECM)成分的研究结果。检索PubMed和Embase存储库。在检索到的5083篇文章中,共有37篇文章符合资格标准并被纳入审查。数据提取后,文章分为以下几类:1)“抗凋亡/抗炎/抗氧化剂”,2)“激素”,3)“磺脲类”,4)“血清补充剂”,5)“支架或ECM成分”。综述的添加剂、ECM或支架对胰岛活力、细胞凋亡和功能(葡萄糖刺激的胰岛素分泌-GSIS)的影响是异质的,使得任何重大结论都难以维持。总的来说,一些“抗凋亡/抗炎/抗氧化”添加剂减少了细胞凋亡,改善了GSIS。此外,使用ECM成分或支架的胰岛培养增加了GSIS。需要更多的研究来确定这些策略在改善胰岛移植结果方面的真正影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Islets
Islets ENDOCRINOLOGY & METABOLISM-
CiteScore
3.30
自引率
4.50%
发文量
10
审稿时长
>12 weeks
期刊介绍: Islets is the first international, peer-reviewed research journal dedicated to islet biology. Islets publishes high-quality clinical and experimental research into the physiology and pathology of the islets of Langerhans. In addition to original research manuscripts, Islets is the leading source for cutting-edge Perspectives, Reviews and Commentaries. Our goal is to foster communication and a rapid exchange of information through timely publication of important results using print as well as electronic formats.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信